Updated on 15 September 2026
AI in pharma
Founder and CEO at Tycho
Bergamo, Italy
About
Pharma AI Expertise at TychoDecades of Domain Leadership
-
Biopharma Depth: Built on 20+ years of hands-on drug discovery experience across target validation, structural biology, and hit-to-lead programs.
-
Cross-Disciplinary Fluency: Seamlessly bridging biological domain knowledge with modern computational architectures and software design.
Applied AI & Computational Integration
-
Practical ML Deployment: Implementing generative frameworks and machine learning models tailored to high-value industrial problems.
-
End-to-End Alignment: Harmonizing wet-lab execution, data governance, and AI pipelines to create scalable, high-conviction TechBio platforms.
Strategic & Operational Impact
-
De-Risked Innovation: Delivering bespoke computational workflows without generic platform lock-in or proprietary vendor constraints.
-
Executive Advisory: Partnering with investors and leadership teams to evaluate TechBio opportunities and drive pipeline advancement.
Similar opportunities
Service
Drug Discovery and development AI leadership
- Consulting
- Innovation management
- Research & Development
- Education, Training & Qualifying
Alberto Bresciani
Founder and CEO at Tycho
Bergamo, Italy